[go: up one dir, main page]

FI954213L - Tumörmotverkande kompositioner och behandlingsmetoder - Google Patents

Tumörmotverkande kompositioner och behandlingsmetoder Download PDF

Info

Publication number
FI954213L
FI954213L FI954213A FI954213A FI954213L FI 954213 L FI954213 L FI 954213L FI 954213 A FI954213 A FI 954213A FI 954213 A FI954213 A FI 954213A FI 954213 L FI954213 L FI 954213L
Authority
FI
Finland
Prior art keywords
treatment methods
antitumor compositions
antitumor
compositions
treatment
Prior art date
Application number
FI954213A
Other languages
English (en)
Finnish (fi)
Other versions
FI954213A0 (sv
Inventor
Gerald Burr Grindey
Cora Sue Grossman
James Jeffry Howbert
James Edward Ray
John Eldon Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI954213A0 publication Critical patent/FI954213A0/sv
Publication of FI954213L publication Critical patent/FI954213L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI954213A 1993-03-10 1995-09-08 Tumörmotverkande kompositioner och behandlingsmetoder FI954213L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2909593A 1993-03-10 1993-03-10
PCT/US1994/002606 WO1994020101A1 (en) 1993-03-10 1994-03-10 Antitumor compositions and methods of treatment

Publications (2)

Publication Number Publication Date
FI954213A0 FI954213A0 (sv) 1995-09-08
FI954213L true FI954213L (sv) 1995-10-11

Family

ID=21847185

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954213A FI954213L (sv) 1993-03-10 1995-09-08 Tumörmotverkande kompositioner och behandlingsmetoder

Country Status (20)

Country Link
EP (1) EP0614887B1 (sv)
JP (1) JPH08507532A (sv)
KR (1) KR960700710A (sv)
AT (1) ATE154345T1 (sv)
AU (1) AU687042B2 (sv)
BR (1) BR9405997A (sv)
CA (1) CA2157801A1 (sv)
CZ (1) CZ232695A3 (sv)
DE (1) DE69403695T2 (sv)
DK (1) DK0614887T3 (sv)
ES (1) ES2102774T3 (sv)
FI (1) FI954213L (sv)
GR (1) GR3023827T3 (sv)
HU (1) HU218660B (sv)
NO (1) NO953557L (sv)
NZ (1) NZ263080A (sv)
PL (1) PL310558A1 (sv)
RU (1) RU2127259C1 (sv)
WO (1) WO1994020101A1 (sv)
ZA (1) ZA941500B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1079096C (zh) * 1996-08-22 2002-02-13 同和药品工业株式会社 用作抗肿瘤剂的芳磺酰基咪唑啉酮衍生物
DE19919793A1 (de) 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
US7282595B2 (en) 2002-11-22 2007-10-16 Eli Lilly And Company Antitumor benzoylsulfonamides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
NZ238911A (en) * 1990-07-17 1993-10-26 Lilly Co Eli Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
NO953557D0 (no) 1995-09-08
EP0614887A1 (en) 1994-09-14
AU6363894A (en) 1994-09-26
NZ263080A (en) 1996-12-20
JPH08507532A (ja) 1996-08-13
CA2157801A1 (en) 1994-09-15
ZA941500B (en) 1995-09-04
WO1994020101A1 (en) 1994-09-15
GR3023827T3 (en) 1997-09-30
EP0614887B1 (en) 1997-06-11
PL310558A1 (en) 1995-12-27
NO953557L (no) 1995-11-02
CZ232695A3 (en) 1996-01-17
HU218660B (hu) 2000-10-28
ATE154345T1 (de) 1997-06-15
AU687042B2 (en) 1998-02-19
FI954213A0 (sv) 1995-09-08
RU2127259C1 (ru) 1999-03-10
DE69403695T2 (de) 1997-10-30
DE69403695D1 (de) 1997-07-17
BR9405997A (pt) 1995-12-19
HUT72897A (en) 1996-06-28
DK0614887T3 (da) 1997-10-20
ES2102774T3 (es) 1997-08-01
HU9502627D0 (en) 1995-11-28
KR960700710A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
FI953593L (sv) G-CSF-analogkompositioner och förfaranden
FI961599A (sv) 1N-alkyl-N-arylpyrimidinaminer och derivat därav
FI953351L (sv) Blandningar och deras användning
FI944310A0 (sv) Heteroarylamino- och heteroarylsulfonamidosubstituerade 3-bensylaminometylpiperidiner och motsvarande föreningar
FI943345L (sv) Organalumoxanprodukter och deras användning
FI951413L (sv) Ytbehandlingskomposition
FI940640L (sv) Organoaluminoxyprodukter samt användning
BR9106438A (pt) Composicoes terapeuticas sinergisticas e processos
FI945625L (sv) Indolkarbazol-imider och deras användning
FI970920L (sv) Trifenyletylener för användning vid förebyggande och behandling av osteoporos
DE69607952D1 (de) Organoboran-polyaminkomplexe und damit hergestellte klebstoffzusammensetzungen
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
DE69322395D1 (de) Feuerbeständige und hochtemperaturisolierende zusammensetzung
BR1100824A (pt) Composto e composição farmacêutica
FI941137L (sv) 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa
FI951197L (sv) Mikrobicidiska sammansättningar och förfaranden
DE69430420D1 (de) Pektin, Verfahren und Zusammensetzung
DE69430170D1 (de) Pektin, Verfahren und Zusammensetzung
FI935728L (sv) Substituerade 4-fenylpyridoner och 4-fenyl-2-alkoxipyridiner
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
NO912773L (no) Antitumor-sammensetninger og fremgangsmaater for behandling
FI955426L (sv) Ytbehandlingsprodukter och förfaranden för deras framställning
FI951060L (sv) Formulationer och behandlingsmetoder
FI965008L (sv) Sammansättningar och förfaranden för tumörbehandling
FI955123A0 (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma